Related Experiment Video
Updated: Mar 19, 2026
07:53
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
7.8K
Mighty mouse breakthroughs: a Sox2-driven model for squamous cell lung cancer.
Anandaroop Mukhopadhyay1, Trudy G Oliver1
1Department of Oncological Sciences; University of Utah and Huntsman Cancer Institute ; Salt Lake City, UT USA.
Molecular & Cellular Oncology
|June 17, 2016
Summary
Researchers developed a new mouse model for squamous lung cancer by manipulating Sex-determining region Y-box 2 (Sox2) and liver kinase B1 (Lkb1). This model accurately mimics human squamous lung carcinoma for preclinical research.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Squamous lung cancer, a non-small cell lung cancer subtype, has a poor prognosis.
- Current preclinical models may not fully recapitulate human disease characteristics.
Purpose of the Study:
- To develop a novel and accurate mouse model for squamous lung carcinoma.
- To facilitate preclinical studies for squamous lung cancer therapies.
Main Methods:
- Overexpression of Sex-determining region Y-box 2 (Sox2) in mouse lung tissue.
- Deletion of liver kinase B1 (Lkb1) using a lentiviral delivery system.
Main Results:
- The generated mouse model exhibits histopathology similar to human squamous lung cancer.
- Biomarker expression and signaling pathway activation in the model align with human disease.
- The model demonstrates high fidelity for recapitulating key features of human squamous lung carcinoma.
Conclusions:
- The Sox2-overexpressing, Lkb1-deficient mouse model is a valuable tool for squamous lung cancer research.
- This model provides a robust platform for preclinical testing of novel therapeutic strategies.
- Further investigation using this model can advance understanding and treatment of non-small cell lung cancer.
